This month, the discussion group debated the advantages and disadvantages of different types of inhalers. One key area of interest was current-day challenges with aerosol delivery, which could be addressed through smart inhalers and other innovative new devices.

How do we make the most of new techniques to optimise product development?

Beyond the blood–brain barrier, the pulmonary power of nebulisers, and RNA science in the post-COVID era

The pharmaceutical industry has historically taken a cautious approach to most new advancements, but now it is embracing the possibilities of continuous manufacturing technologies. While traditional batch-based processes are still more common, there are several products on the market that have utilized continuous manufacturing practices.

RNA based therapeutics, particularly mRNA, has been experiencing a period of rapid growth, partly due to the influx of funding for mRNA Covid-19 Vaccines. One area that has the potential to benefit from mRNA vaccines is cancer. There are various techniques that have potential to combat the deadly disease.   

This event brought over 600 leading industry minds together to discuss the latest crucial developments in RNA based therapeutics, from mRNA in vaccine development through to microRNA, siRNA, as well as antisense and RNA interference. RNA Therapeutics & Delivery US: Online featured two days of cutting-edge exhibitions and knowledge sharing, consisting of over 30 presentations, roundtables, panel discussions and ask-the-expert Q&As taking place across both days of the event.